TriSalus Life Sciences, Inc. (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

3.700

+0.050 (1.37%)

At close: Aug 13, 2025, 4:00 PM

3.950

+0.250 (6.76%)

After-hours: Aug 13, 2025, 4:10 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Innovative Drug Delivery Technology and Immune-oncology Therapeutics	18.51M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	18.51M